Amarin wants fourth omega-3 API supplier for AM101
Amarin plans to add a fourth API maker to its supply chain as it prepares for a potential launch of its triglyceride lowering therapy, AMR101, in the US in 2012.
Archives for January 11, 2012
Sanofi to make $170m cuts in operational costs
Sanofi announced it will cut $170m of its operational costs this year as it plans to ramp-up acquisitions spending to $2.6bn.
ShangPharma opens new plant to meet Lilly's R&D needs
ShangPharma has revealed its newly opened 100,000 sq foot facility will serve the growing capacity needs of pharma giant Eli Lilly.
Collaboration needed to reverse supply chain “neglect”; expert
Greater collaboration between regulators, suppliers and manufacturers is needed to reverse decades of supply chain neglect, an expert said.
Catalent to build biologics plant at former GE Healthcare facility
US contractor Catalent Pharma Solutions’ new biologics plant will be a facility formerly owned by GE Healthcare.
Ashland to boost disintegrant capacity at Texas plant
Ashland says it will ramp up production of the tablet disintegrant and dissolution aid polyvinylpyrrolidone (PVPP) to meet growing drug industry demand.
Bumpy road ahead for Hospira but issues “fixable”, CEO says
Hospira will uncover more issues as it gets to the root cause of its quality troubles but the situation is “very fixable”, its CEO said.
CRO consolidation to slow in 2012, Icon CEO says
Major CRO consolidation will slow down in 2012 after the big wave of deals last year, the CEO of Icon said.